Hillhouse and Tencent!The first new shares in the year of the tiger, the vaccine industry leading to


A shares will usher in the first trading day of the Year of the Tiger tomorrow, and will also usher in the first batch of new shares in the year of the Tiger.According to the arrangement of new issues, there are six new shares in Shanghai and Shenzhen next week.Among them, Hefu China, which listed on the main board in Shanghai next Monday, priced below 5 yuan.Data show that low-price shares tend to rise higher after listing;Hualan Vaccine, which will be listed on gem next Tuesday, is a leading manufacturer in the domestic vaccine industry.The first batch of new shares in the year of the Tiger will start to apply for two new shares next Monday, which are listed on the Main board of the Shanghai Stock Exchange, Hefu China, and the Science and Technology Innovation Board.Hefu China is a channel provider in the field of medical circulation. Its ipo price is 4.19 yuan/share, with an ipo price/earnings ratio of 22.99 times and a reference industry price/earnings ratio of 18.74 times. The maximum application shall be matched with the Shanghai market value of 390,000 yuan.Data show that Hefu China has established cooperative relations with more than 100 primary in vitro diagnostic reagent projects of tertiary hospitals, providing intensive procurement services for in vitro diagnostic products to hospitals.In terms of performance, during the reporting period (2018, 2019, 2020 and January-September 2021), the company achieved net profit of 67 million yuan, 67 million yuan, 73 million yuan and 54 million yuan respectively.The company expects to achieve a net profit of 79 million yuan to 83 million yuan in 2021, up 8.92% to 14.37% from 2020.In the past, low-priced ipos tend to rise higher.In 2021, a total of 14 stocks listed on the main boards of The Shanghai and Shenzhen stock exchanges saw their ipo prices lower than 5 yuan per share, and they gained an average of 8.5 one-word daily limit after listing. Among them, 8 stocks saw their one-word daily limit amount reach or exceed 10.Data source: Wind catalyst is the domestic special catalyst leader, its issue price is 41.90 yuan/share, the issue p/E ratio is 85.98 times, the reference industry P/E ratio is 42.78 times, the top application needs to match Shanghai market value of 110,000 yuan.Medium to raise the capital of 784 million yuan, and the actual net raised capital reached 1.691 billion yuan, overraised multiple of 2.16 times.Materials show that The catalyst is mainly engaged in special molecular sieve and catalytic new materials products research and development, production, sales and chemical technology, chemical process services.In terms of performance, during the reporting period (2018, 2019, 2020 and January-September 2021), the company achieved net profit of 900 million yuan, 53 million yuan, 92 million yuan and 116 million yuan respectively.The company expects to achieve a net profit of 124 million to 144 million yuan in 2021, up about 35.02% to 56.80% compared with 2020.The leading producer in the domestic vaccine industry is Hualan Vaccine, a new stock on gem that will be subscribed next Tuesday.Hualan vaccine has not yet announced the issue price, the maximum application for shenzhen market value of 65,000 yuan.Hualan vaccine plans to issue 40.01 million shares, which is expected to raise 2.526 billion yuan. According to the calculation, the issue price may reach about 60 yuan.Data show that hualan vaccine, as the largest influenza vaccine r&d and production enterprise in China, has been focusing on human vaccine r&d and production for many years. Its capacity, sales volume and market share of influenza vaccine have ranked first in China for several consecutive years.The company’s listed products include viral vaccines, bacterial vaccines and recombinant vaccines.In terms of performance, the company achieved net profit of 270 million YUAN, 375 million yuan, 925 million yuan and 528 million yuan respectively during the reporting period (2018, 2019, 2020 and January-September 2021).The company expects to achieve full-year net profit of 740 million yuan to 1.017 billion yuan in 2021, a change of -20% to 10% from 2020.According to the prospectus disclosed by Hualan Vaccine on January 24, the controlling shareholder of the company is Hualan Biological, which is mainly engaged in the research and development, production and sales of blood products, holding 75% of the shares.In addition, Henan Hillhouse Huayin Enterprise Management Consulting Partnership (limited partnership) (referred to as “Hillhouse huayin”) holds 9% shares of Hualan Vaccine, and Xinxiang Chenyi Qiming Management Consulting Partnership (limited partnership) (referred to as “Chenyi Qiming”) holds 6% shares of the company.Hualan vaccines remains a controlling subsidiary of the company and will be incorporated into hualan’s financial statements, hualan said on its investor interactive platform on Jan 29.Tianyan examination shows that the three shareholders of Hillhouse are Shenzhen Hillhouse Tiancheng Phase III Investment Co., LTD., Shenzhen Hillhouse Muqi Equity Investment Fund Partnership (limited partnership), and Shenzhen Hillhouse Kunqi Equity Investment Fund Partnership (limited partnership).Among them, Shenzhen Hillhouse Muqi Equity Investment Fund Partnership (limited partnership) holds nearly 90% of the shares, and the largest shareholder of the company is Shenzhen Tencent Industrial Investment Fund Co., LTD., holding 34.18%.Explain buy new information in next week and rich China: mainly engaged in the circulation of intensification of in vitro diagnostic products, medical products and other value-added services in the catalyst, is mainly engaged in special molecular sieve and new catalytic materials products research and development, production, sales and chemical technology, chemical technology service westlands vaccine: mainly engaged in people with a vaccine research and development, production and sales brand equity:Biyi Shares: Mainly engaged in the design, manufacture and sales of small kitchen appliances such as air fryers, air ovens, deep fryers and fryers.From The New Year’s Eve to the sixth day of the lunar New Year, Zhongzheng Jun will prepare a # topic # in his wechat article every day, welcome you to leave a message at the end of the article interaction.CSJ will select the best message from all the readers and give you a prize, which will be sent to you after the Spring Festival.Tomorrow is the first trading day of the Year of the Tiger. Can we get off to a good start?Share your views and trading strategies for the year of the Tiger.For example, which sectors and stocks are good?Are you ready for the long term or the short term?Buy stocks or funds?The deadline for comments is 24 hours after the article is published, Zhongzechenjun will select 50 lucky fans to win the prize.Editor: Li Ruoyu, Xu Xiaohong

Leave a Reply

Your email address will not be published.